Aug 2026
Effectiveness of anti-CD19 CAR T-cell therapy for high-grade B-cell lymphoma in Japan: a single-institution analysis.
The efficacy of CAR T-cell therapy in patients with R/R HGBCL remains suboptimal, and high-grade morphology may help identify patients at particularly high risk of poor outcomes following CAR T-cell therapy.
T. Ochi, S. Makita, Anna Hiratsuka et al.
· International Journal of Cli... · 0 citations